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Peripartum cardiomyopathy is a serious, potentially life-threatening heart disease of uncertain aetiology in previously healthy
women. We report a morbidly obese woman who presented with peripartum shortness of breath. We discuss the diﬀerential
diagnosis of dyspnoea in pregnancy and highlight the complexity of care of the morbidly obese woman.
1.Introduction
Maternal obesity is associated with an increased risk of
complications for the mother and her oﬀspring during
pregnancy, at delivery and during the postpartum period
[1, 2]. Although dyspnoea is a common symptom in obese
pregnant women, other diﬀerential diagnoses, however,
should not be overlooked.
Peripartum cardiomyopathy (PPCM), for example, is a
rare and potentially life-threatening diﬀerential diagnosis.
This report highlights the complexity of care which may be
required for a morbidly obese pregnant woman.
2.CaseReport
A 35-year-old European ﬁrst-time mother with an un-
planned pregnancy presented late for antenatal care at 35
weeks gestation. In her past medical history, she had asthma
forwhichshewasusingasalbutamolinhaler.Atpresentation
her weight was 147kg and her Body Mass Index (BMI) was
54kg/m2. An oral glucose tolerance test was normal. She was
seen regularly in the antenatal clinic where she was found
to be normotensive with no proteinuria. At her visits she,
however, did complain of dyspnoea on exertion, bilateral
leg swelling, and excessive weight gain especially in the third
trimester. However, these ﬁndings were attributed to her
pregnancy.
At 40 weeks and three days, she presented with bilateral
legoedema,erythema,andtenderness.Shewasadmittedand
had a Doppler ultrasound performed which ruled out a deep
venous thrombosis. She was treated with antibiotics and had
physiotherapy. An ultrasound scan was performed to assess
fetal well-being which estimated the fetal weight to be 4755g
anddemonstratedpolyhydramnios.At41weeksandoneday,
thepatienthadprelabourruptureofhermembranesandwas
induced after 24 hours with an oxytocin infusion.
On the delivery suite, it was diﬃcult to monitor the fetal
heart rate by an external monitor and a fetal scalp electrode
was applied. The patient was contracting eﬃciently on the
oxytocin. An epidural was sited, which made it diﬃcult to
palpate the contractions. There was no change in the cervical
dilationafterbeingsixhoursontheoxytocininfusionandan
emergency caesarean section was carried out.
There was abdominal subcutaneous oedema and ascites
noted at the caesarean section. Although the procedure was
technically diﬃcult due to maternal size, there were no
complications.Ahealthymalewasdeliveredweighing4750g.
Prophylactic antibiotics and low molecular weight heparin
were prescribed postoperatively.
On day four, the woman complained of chest tightness
and dyspnoea. On examination, she was noted to have
a tachycardia. She was normotensive and apyrexial. Her
oxygen saturation was 97% on room air and an arterial
blood gas was normal. On auscultation of her lungs, there
was a bilateral wheeze noted and her heart rate was regular
with an S3 gallop. An electrocardiogram showed a normal
sinus rhythm. A computed tomography was performed
which demonstrated mild inﬂammatory changes and
ruled out a pulmonary embolism. She was commenced on
antibiotics, nebulisers, and intravenous hydrocortisone to2 Case Reports in Obstetrics and Gynecology
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treat an exacerbation of asthma, possibly due to a chest in-
fection. The following day her dyspnoea increased with
no change in her clinical examination. A chest X-ray perf-
ormed demonstrated cardiomegaly with increased vascular
congestion bilaterally (Figure 1). An arterial blood gas on
room air demonstrated hypoxia.
She was transferred to the intensive care unit where
a transthoracic echocardiogram demonstrated a globally
hypokinetic left ventricle, an ejection fraction of less than
30%, and mild/moderate tricuspid regurgitation. The work-
ing diagnosis at this point was peripartum cardiomyopathy
with a superimposed respiratory tract infection. She was
given frusemide and a glyceryl trinitrate infusion for the
management of her pulmonary oedema and ﬂuid overload.
The antibiotics were continued for the suspected superim-
posed infection.
After the initial treatment, she was commenced on an
ACE inhibitor and beta-blocker for the long-term manage-
mentofcardiomyopathyandwasdischargedhomeonday14
postpartum. An echocardiogram at ﬁve months postpartum
showed a left ventricular EF of 50% and the ACE inhibitor
and a Beta Blocker were continued. At six months postpar-
tum, a Mirena coil was inserted for contraceptive purposes.
3. Discussion
Obesity is an increasing problem and presents one of the
greatest challenges to the practising clinician, across all dis-
ciplines. The incidence of obesity has increased dramatically
over the past twenty years. The prevalence of adult obesity
exceeds15%inmostcountries,20%inIrelandandtherestof
Europe, and more than 30% in the United States of America
[2].
Maternal obesity is associated with an increase in
medical complications such as gestational diabetes mellitus,
pre-eclampsia/hypertension,venousthromboembolism,and
infection. Women who are obese have an increased rate of
obstetric interventions such as induction of labour, operative
vaginal delivery, and caesarean section. Women who are
obese are more likely to havepregnancies with fetal com-
plications such as congenital malformations, unexplained
stillbirth, fetal macrosomia, and dizygotic twins. After deliv-
ery, obese mothers have an increased rate of postpartum
haemorrhage and of diﬃculties with breastfeeding [1, 2].
Delivering care to obese women is challenging, par-
ticularly in cases of morbid obesity (BMI > 39.9kg/m2).
Excessive maternal adiposity hinders antenatal fetal assess-
ment by ultrasound, hinders intravenous access and epidural
anaesthesia, and hinders operative exposure when surgical
intervention is necessary. Our case also highlights that
although dyspnoea is a common symptom in obese pregnant
women, other diﬀerential diagnoses need, however, not be
overlooked.
PPCM is a rare but potentially life-threatening disorder
ofunknownaetiologyandpathophysiology.Theincidenceof
PPCM varies worldwide [3]. Reported incidence of PPCM in
non-African countries ranges between 1:3,000 to 1:15,000
live births [4, 5]. The diagnosis of PPCM is based on
four primary diagnostic criteria, and these are (1) the
development of the disease in the last month of pregnancy
or within 5 months of delivery, (2) absence of an identiﬁable
cause of heart failure, (3) absence of recognisable heart
disease before the last month of pregnancy, and (4) left
ventricular systolic dysfunction demonstrated by classical
echocardiographic criteria [6].
ThestrongestriskfactorforPPCMappearstobeAfrican-
American ethnicity [7]. Other reported risk factors include
age, pregnancy-induced hypertension or preeclampsia, mul-
tiparty, multiple gestations, obesity, chronic hypertension,
and prolonged use of tocolytics [8, 9]. Symptoms of PPCM
include fatigue, oedema, and dyspnoea [10]. Other unusual
presentations include multiple thrombotic events and acute
hypoxia [11, 12]. Signs can include tachycardia, pulmonary
rales, and an S3 heart sound [13]. Such signs and symptoms
overlap with those of many other conditions, ranging
from normal pregnancy to pulmonary emboli and upper
respiratory infection.
ECG abnormalities are often noted on presentation,
most commonly sinus tachycardia, nonspeciﬁc ST segment
changes, LV hypertrophy, premature ventricular contraction,Case Reports in Obstetrics and Gynecology 3
and bundle branch block [14]. However, the ECG may
show no changes [15]. Chest radiographs can show signs
of pulmonary congestion and cardiac enlargement and
even pleural eﬀusions in some cases [16]. Echocardiograms
usually show decreased contractility and LV enlargement
without hypertrophy [5].
The treatment of PPCM is the same as for other forms
of congestive heart failure, except angiotensin converting
enzyme inhibitors and angiotensin receptor blockers, which
are contraindicated in pregnancy [17]. Patients with PPCM
are also at high risk of thrombus formation and anticoagula-
tion should be considered [18]. The best time to discontinue
these medications is unknown but their use should be
continued for at least one year [19]. If medical treatment is
not successful, heart transplantation may be the last resort.
About half the women are expected to fully recover
cardiac function [17]. Regardless of recovery, however, a
second pregnancy is usually not recommended as PPCM
recurs in more than 30% of subsequent pregnancies which
puts mother and baby at great risk [17].
Ourcasehighlightsthepotentialcomplexityofmanaging
morbidly obese pregnant women. Although there may be a
focusoncommoncomplicationsassociatedwithobesity,one
needs to be vigilant for the less common complications such
as PPCM.
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